Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GIVLAARI® safely and effectively. See full prescribing information for GIVLAARI. GIVLAARI (givosiran) injection, for subcutaneous use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP).
- generic_name
- givosiran sodium
- product_names
- givosiran sodium
- ndc
- 71336-1001, 71336-1001-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en